Covered recipient · General Payments record
GARY PARTIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,604.18
- Reported across 198 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.04 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $151.73 | 12 |
| SHIELD THERAPEUTICS INC | $124.22 | 1 |
| Lilly USA, LLC | $46.43 | 3 |
| Amgen Inc. | $32.83 | 2 |
| GlaxoSmithKline, LLC. | $30.55 | 2 |
| Acerta Pharma LLC | $28.81 | 2 |
| Vanda Pharmaceuticals Inc. | $26.00 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.24 | 1 |
| PFIZER INC. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.35 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188056 | CMS |
| ABBVIE INC. | $4.24 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188058 | CMS |
| ABBVIE INC. | $16.03 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188060 | CMS |
| ABBVIE INC. | $16.89 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188062 | CMS |
| ABBVIE INC. | $12.26 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188064 | CMS |
| ABBVIE INC. | $17.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188066 | CMS |
| ABBVIE INC. | $1.80 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188068 | CMS |
| ABBVIE INC. | $17.82 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188070 | CMS |
| ABBVIE INC. | $18.18 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188072 | CMS |
| ABBVIE INC. | $2.46 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188074 | CMS |
| ABBVIE INC. | $13.37 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188076 | CMS |
| ABBVIE INC. | $19.51 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105188078 | CMS |
| Amgen Inc. | $14.97 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117347752 | CMS |
| Amgen Inc. | $17.86 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117347754 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.42 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110540119 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.39 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110537519 | CMS |
| GlaxoSmithKline, LLC. | $14.49 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115832756 | CMS |
| GlaxoSmithKline, LLC. | $16.06 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116497438 | CMS |
| Lilly USA, LLC | $15.21 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134984044 | CMS |
| Lilly USA, LLC | $13.99 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135001846 | CMS |
| Lilly USA, LLC | $17.23 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135001972 | CMS |
| PFIZER INC. | $14.23 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132124913 | CMS |
| SHIELD THERAPEUTICS INC | $124.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150118613 | CMS |
| Vanda Pharmaceuticals Inc. | $26.00 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133915409 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.24 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144595156 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.